Beth Musser
University of Washington
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Beth Musser.
European Journal of Pharmacology | 1993
Beth Musser; Michael Morgan; Mark Leid; Thomas F. Murray; Joel Linden; Robert E. Vestal
The antagonist radioligand 1,3-[3H]dipropyl-8-cyclopentylxanthine ([3H]DPCPX) was used to characterize adenosine A1 receptors in membrane preparations from atrial and ventricular myocardium of rat, rabbit, guinea pig and pig. Kd values in crude membranes from guinea pig atria and ventricles (3.3 and 3.0 nM) were higher than those in the other species (ranges, 1.5-1.8 and 1.5-1.9 nM). Bmax values were greater in atria than in ventricles in all four species, and in atria and ventricles of guinea pig (76 and 34 fmol/mg), than in the other species (ranges, 15-17 and undetectable to 12 fmol/mg). In contrast, guinea pig Kd and Bmax values for beta-adrenoceptors, which were labelled with (-)3-[125I]iodocyanopindolol, fell within the range of values for the other three mammalian species. In semipurified membrane preparations from pig, [3H]DPCPX and the agonist radioligand [125I]-N6-4-aminobenzyladenosine appeared to label a similar population of receptors and gave comparable Kd values in atria (0.73 and 0.66 nM) and in ventricles (0.57 and 0.70 nM). In semipurified preparations from pig, the agonist R-(-)-N6-(2-phenylisopropyl)adenosine (R-PIA) displaced [3H]DPCPX in a manner consistent with the presence of both high- and low-affinity adenosine A1 receptors. The data from this study indicate that the density of adenosine A1 receptors in atria is greater than in ventricles, but similar Kd values suggest that the A1 receptor population is the same in the two cardiac tissues. Also, the data demonstrate that the [3H]DPCPX antagonist binding characteristics of guinea pig myocardium differ from those in rat, rabbit and pig.
Life Sciences | 2003
Chris L. Kapicka; Stephen C. Montamat; Richard D. Olson; Beth Musser; Ramagopal V. Mudumbi; Robert E. Vestal
Various species have been used as models to study the effects of adenosine (ADO) on atrial and ventricular myocardium, but few direct tissue comparisons between species have been made. This study further characterizes adenosine A(1) receptor binding, adenylate cyclase activity and direct and indirect A(1) receptor-mediated functional activity in atrial and ventricular tissue from Sprague-Dawley rats and Hartley guinea pigs. Rat right atria (RA) were found to be significantly more sensitive to cyclopentyladenosine (CPA), while guinea pig left atria (LA) were more sensitive to CPA. After the addition of isoproterenol (ISO), the reduction of CPA response in rat RA was significantly greater than in guinea pig; however, after ISO treatment, the guinea pig LA was more sensitive to CPA than the rat. Adenylate cyclase inhibition by CPA was significantly greater in atria and ventricles obtained from guinea pig than rat. In competition binding experiments, guinea pig RA had significantly more high affinity sites than rat, but the K(i)s were not significantly different. There were no significant differences between guinea pig LA and rat LA. Guinea pig ventricular tissue had fewer high affinity sites than rat without any differences in their K(i) values. In antagonist saturation experiments, the density and affinity of A(1) receptors in guinea pig cardiac membranes were significantly greater than in rat. Our results indicate definite species differences as well as tissue differences between rat and guinea pig. These differences must be considered when interpreting studies using rat and guinea pig tissue as models for cardiac function.
Clinical Pharmacology & Therapeutics | 2006
Barry J. Cusack; H Gambliel; Beth Musser; N Hadjokas; S Shadle; H Charlier; Richard D. Olson
Anthracyclines, such as doxorubicin and daunorubicin, can cause chronic, cumulative dose‐related cardiotoxicity. This can be prevented by dexrazoxane, a putative iron chelator. Disorders of iron metabolism, including altered IRP1‐IRE binding may be an important mechanism of anthracycline cardiotoxicity. This study was designed to examine the role of IRP1‐IRE binding in a chronic model of daunorubicin cardiotoxicity and whether dexrazoxane could prevent such changes in IRP1‐IRE binding due to daunorubicin.
European Journal of Pharmacology | 1996
Beth Musser; Michael Morgan; Mark Leid; Thomas F. Murray; Joel Linden; Robert E. Vestal
Abstract The antagonist radioligand 1,3-[3H]dipropyl-8-cyclopentylxanthine ([3H]DPCPX) was used to characterize adenosine A1 receptors in membrane preparations from atrial and ventricular myocardium of rat, rabbit and guinea pig. Kd values in crude membranes from guinea pig atria and ventricles (3.3 and 3.0 nM) were higher than those in the other species (ranges, 1.5–1.8) and 1.5–1.9 nM). Bmax values were greater in atria than in ventricles in all four species, and in atria and ventricles of guinea pig (76 and 34 fmol/mg), than in the other species (ranges, 15–17 and undetectable to 12 fmol/mg). In contrast, guinea pig Kd and Bmax values for β-adrenoceptors, which were labelled with (−)-3-[125I]iodocyanopindolol, fell within the range of values for the other three mammalian species. In semipurified membrane preparations from pig, [3H]DPCPX and the agonist radioligand [125I]N6-4-aminobenzyladenosine appeared to label a similar population of receptors and gave comparable Kd values in atria (0.73 and 0.66 nM) and in ventricles (0.57 and 0.70 nM). In semipurified preparations from pig, the agonist R-(−)-N6-(2-phenylisopropyl)adenosine (R-PIA) displaced [3H]DPCPX in a manner consistent with the presence of both high- and low-affinity adenosine A1 receptors. The data from this study indicate that the density of adenosine A1 receptors in atria is greater than in ventricles, but similar Kd values suggest that the A1 receptor population is the same in the two cardiac tissues. Also, the data demonstrate that the [3H]DPCPX antagonist binding characteristics of guinea pig myocardium differ from those in rat, rabbit and pig.
Clinical Pharmacology & Therapeutics | 1996
Robert E. Vestal; Beth Musser; J. Liu; Richard D. Olson; R.V. Mudumbi
Clinical Pharmacology & Therapeutics (1996) 59, 175–175; doi: 10.1038/sj.clpt.1996.200
Journal of Pharmacology and Experimental Therapeutics | 1999
Beth Musser; Ramagopal V. Mudumbi; Jingwen Liu; Richard D. Olson; Robert E. Vestal
Cancer Chemotherapy and Pharmacology | 2006
Barry J. Cusack; Hervé Gambliel; Beth Musser; Nicholas Hadjokas; Susan E. Shadle; Henry A. Charlier; Richard D. Olson
Journal of Mass Spectrometry | 1982
Robert E. Vestal; Kenneth E. Thummel; Beth Musser; Sandra G. Jue; Gary D. Mercer; William N. Howald
Cancer Chemotherapy and Pharmacology | 2003
Barry J. Cusack; Beth Musser; Hervé Gambliel; Nicholas Hadjokas; Richard D. Olson
Journal of Pharmacological and Toxicological Methods | 1994
Christopher K. Daniels; Lurong Zhang; Beth Musser; Robert E. Vestal